Recursion Pharmaceuticals Inc vs Teucrium Wheat Fund — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Teucrium Wheat Fund trades at $25.21. The key difference: Teucrium Wheat Fund is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | WEAT | |
|---|---|---|
Market Cap | $1.53B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $6.79 | $25.49 |
52-Week Low | $2.84 | $19.88 |
Enterprise Value | $946.50M | — |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →